19 July 2023 - In a move that will further damage UK life sciences investment, the Government has launched a consultation into radically changing the Statutory Scheme for branded medicines.
The consultation comes as delicate negotiations for replacing the alternative Voluntary Scheme are underway, potentially undermining these talks, while also further damaging industry confidence in the UK as a viable place to research, launch and supply medicine.